| scholarly article | Q13442814 |
| P50 | author | Nitin J Karandikar | Q56285632 |
| Sterling B Ortega | Q59682897 | ||
| P2093 | author name string | Vinodh Pillai | |
| C K Wang | |||
| P2860 | cites work | Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation | Q24291515 |
| Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells | Q24298812 | ||
| Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells | Q24306205 | ||
| Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells | Q24645614 | ||
| Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
| Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection | Q27469828 | ||
| T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. | Q27469830 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity | Q28200074 | ||
| Regulatory T cell lineage specification by the forkhead transcription factor foxp3 | Q28510328 | ||
| CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 | ||
| A new "Logicle" display method avoids deceptive effects of logarithmic scaling for low signals and compensated data | Q31036367 | ||
| Interpreting flow cytometry data: a guide for the perplexed | Q31045140 | ||
| A peripheral circulating compartment of natural naive CD4 Tregs | Q33865874 | ||
| De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells | Q33932462 | ||
| Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development | Q34597933 | ||
| Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis | Q34789216 | ||
| Functional avidity directs T-cell fate in autoreactive CD4+ T cells | Q35848366 | ||
| CD4+ Tregs and immune control | Q35936484 | ||
| Qa-1 restriction of CD8+ suppressor T cells | Q35936489 | ||
| A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. | Q36078042 | ||
| Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells | Q36228688 | ||
| CD4+ regulatory cells as a potential immunotherapy | Q36251271 | ||
| CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status | Q36399748 | ||
| Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis | Q36403300 | ||
| Regulatory T-cell compartmentalization and trafficking | Q36421407 | ||
| FOXP3: of mice and men. | Q36427333 | ||
| The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. | Q41998069 | ||
| TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs | Q42181372 | ||
| Molecular mechanisms underlying FOXP3 induction in human T cells | Q42491664 | ||
| The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. | Q45304800 | ||
| Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. | Q45952178 | ||
| Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity | Q47265853 | ||
| Persistence of naive CD45RA+ regulatory T cells in adult life. | Q51986549 | ||
| Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. | Q52932694 | ||
| Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. | Q54645452 | ||
| Can super-antibody drugs be tamed? | Q56674040 | ||
| Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist | Q56903962 | ||
| FOXP3 Identifies Regulatory CD25brightCD4+ T Cells in Rheumatic Joints | Q57349726 | ||
| CD4+CD25+T Cells in Skin Lesions of Patients with Cutaneous Leishmaniasis Exhibit Phenotypic and Functional Characteristics of Natural Regulatory T Cells | Q57934785 | ||
| Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level | Q60311694 | ||
| Seventeen-colour flow cytometry: unravelling the immune system | Q62577376 | ||
| High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay | Q76376758 | ||
| Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B | Q79755080 | ||
| Regulatory/suppressor T cells in health and disease | Q80806146 | ||
| Inducing and expanding regulatory T cell populations by foreign antigen | Q81392563 | ||
| CD28 superagonists put a break on autoimmunity by preferentially activating CD4+CD25+ regulatory T cells | Q81596148 | ||
| Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2(-/-)gammac(-/-) mice | Q82715228 | ||
| London's disastrous drug trial has serious side effects for research | Q82918022 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 18-29 | |
| P577 | publication date | 2006-12-19 | |
| P1433 | published in | Clinical Immunology | Q15752921 |
| P1476 | title | Transient regulatory T-cells: a state attained by all activated human T-cells | |
| P478 | volume | 123 |
| Q35981603 | 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region |
| Q38872469 | A Bacterial Artificial Chromosome Reporter System for Expression of the Human FOXP3 Gene in Mouse Regulatory T-Cells |
| Q34461203 | A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma. |
| Q36191738 | A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function |
| Q35028105 | A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations |
| Q24304263 | A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells |
| Q37064737 | A pharmacologic perspective on newly emerging T-cell manipulation technologies |
| Q34696683 | A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells |
| Q36362241 | Activation-induced FoxP3 expression regulates cytokine production in conventional T cells stimulated with autologous dendritic cells |
| Q33299427 | Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo |
| Q56899929 | Allogeneic induced human FOXP3(+)IFN-gamma(+) T cells exhibit selective suppressive capacity |
| Q52732451 | Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides. |
| Q30300277 | Analysis of cytokine production by peanut-reactive T cells identifies residual Th2 effectors in highly allergic children who received peanut oral immunotherapy |
| Q37151149 | Antagonism of histamine H4 receptors exacerbates clinical and pathological signs of experimental autoimmune encephalomyelitis. |
| Q80512153 | Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation |
| Q42953763 | Attack on the clones? Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity |
| Q37347729 | Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection |
| Q50281162 | CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from In Vitro Expansion Cultures. |
| Q35025435 | CD4(+)CD62L(+) central memory T cells can be converted to Foxp3(+) T cells |
| Q48259792 | CD4+ regulatory T cells in gastric cancer mucosa are proliferating and express high levels of IL-10 but little TGF-β. |
| Q37794623 | CD4+ regulatory T cells in solid organ transplantation |
| Q36978507 | CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. |
| Q89944708 | CD4+FOXP3+ T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired |
| Q35506606 | CD8(+)/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study |
| Q33889097 | CD8+ Tregs in lupus, autoimmunity, and beyond |
| Q54462329 | Characterization of circulating CD4+CD25high regulatory T cells in men with chronic prostatitis/chronic pelvic pain syndrome. |
| Q35564025 | Choice of resident costimulatory molecule can influence cell fate in human naïve CD4+ T cell differentiation |
| Q35926395 | Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate |
| Q40301941 | Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year |
| Q37944565 | Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management |
| Q36126324 | Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. |
| Q34503547 | DC expressing transgene Foxp3 are regulatory APC. |
| Q52924279 | DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. |
| Q46391168 | DNA methylation controls Foxp3 gene expression |
| Q50872929 | Deregulation from CD4+ memory T cells to regulatory cells in patients with chronic renal failure: a pilot study. |
| Q56890349 | Description of CD8 Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer |
| Q41754216 | Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells |
| Q53498602 | Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation. |
| Q39016358 | Effect of cell density and HLA-DR incompatibility on T-cell proliferation and forkhead box P3 expression in human mixed lymphocyte reaction |
| Q35276622 | Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis |
| Q83125659 | Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? |
| Q54345023 | Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro. |
| Q42589743 | Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells |
| Q41190379 | Evaluation of CD4+ CD25+ FoxP3+ Regulatory T cells and FoxP3 and CTLA-4 gene Expression in Patients wwith Newly Diagnosed Tuberculosis in Northeast of Iran |
| Q34699537 | Expression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells |
| Q33644550 | FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity |
| Q33320522 | FOXP3 promoter demethylation reveals the committed Treg population in humans. |
| Q84278927 | FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome |
| Q35566145 | FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells |
| Q28115088 | Foxp3 is critical for human natural CD4+CD25+ regulatory T cells to suppress alloimmune response |
| Q42518281 | Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus |
| Q36984057 | Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation |
| Q33312509 | GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. |
| Q64230492 | Generation and Immune Regulation of CD4CD25Foxp3 T Cells in Chronic Obstructive Pulmonary Disease |
| Q36938160 | Generation and function of induced regulatory T cells |
| Q34996186 | Generation of human regulatory T cells de novo with suppressive function prevent xenogeneic graft versus host disease |
| Q40055892 | Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3. |
| Q35742927 | Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. |
| Q34019821 | Helios expression is a marker of T cell activation and proliferation. |
| Q36299565 | Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP. |
| Q33931235 | High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population |
| Q36919214 | Histone deacetylase inhibitors and transplantation. |
| Q37596517 | How do regulatory T cells work? |
| Q33525560 | Human CD4 memory T cells can become CD4+IL-9+ T cells |
| Q37524383 | Human FOXP3+ regulatory T cells in transplantation |
| Q37405703 | Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function |
| Q38881545 | Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β. |
| Q85089606 | Human peripheral blood CD8+ CD28- T cells of renal allograft recipients do not express FOXP3 protein |
| Q34636235 | Human regulatory T cells rapidly suppress T cell receptor-induced Ca(2+), NF-κB, and NFAT signaling in conventional T cells. |
| Q36171406 | Human regulatory T cells: a unique, stable thymic subset or a reversible peripheral state of differentiation? |
| Q54427491 | Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire. |
| Q51887184 | Human tumor-infiltrating Th17 cells have the capacity to differentiate into IFN-γ+ and FOXP3+ T cells with potent suppressive function. |
| Q37198900 | IL-15 acts as a potent inducer of CD4(+)CD25(hi) cells expressing FOXP3. |
| Q54562647 | IL-9 contributes to immunosuppression mediated by regulatory T cells and mast cells in B-cell non-hodgkin's lymphoma. |
| Q34037796 | Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity |
| Q51212581 | In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol. |
| Q47929049 | In vitro induction of functional allergen-specific CD4+ CD25high Treg cells in horses affected with insect bite hypersensitivity. |
| Q44638209 | Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients. |
| Q36329777 | Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum |
| Q36059631 | Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype |
| Q87388246 | Induction of antigen-specific human T suppressor cells by membrane and soluble ILT3 |
| Q36994057 | Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis |
| Q33712534 | Inflammatory cues enhance TGFβ activation by distinct subsets of human intestinal dendritic cells via integrin αvβ8. |
| Q36688093 | Inhaled corticosteroid use is associated with increased circulating T regulatory cells in children with asthma |
| Q39332952 | Inhibition of activation induced CD154 on CD4+ CD25- cells: a valid surrogate for human Treg suppressor function |
| Q37037612 | Inhibitory CD8+ T cells in autoimmune disease |
| Q42042533 | Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation |
| Q36608731 | Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer |
| Q35123215 | Loss of Dab2 expression in breast cancer cells impairs their ability to deplete TGF-β and induce Tregs development via TGF-β. |
| Q35077586 | Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinoma. |
| Q36791390 | Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis |
| Q38008361 | Molecular mechanisms of treg-mediated T cell suppression |
| Q37952092 | Molecular mechanisms underlying the regulation and functional plasticity of FOXP3(+) regulatory T cells |
| Q28270037 | Monoclonal antibodies and other biologic agents in the treatment of asthma |
| Q37973770 | Monogenic autoimmunity |
| Q54377708 | Mucosal administration of the B subunit of E. coli heat-labile enterotoxin promotes the development of Foxp3-expressing regulatory T cells. |
| Q26829692 | Panel 5: Microbiology and immunology panel |
| Q92286626 | Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes |
| Q92798698 | Peripheral blood CD4+ T cell populations by CD25 and Foxp3 expression as a potential biomarker: reflecting inflammatory activity in chronic obstructive pulmonary disease |
| Q37076945 | Peripherally induced tregs - role in immune homeostasis and autoimmunity |
| Q37729634 | Plasticity is the differentiated state of CD4 T cells. |
| Q38069412 | Prognostic significance of graft Foxp3 expression in renal transplant recipients: a critical review and attempt to reconcile discrepancies |
| Q41848701 | Proliferation and foxp3 expression in virus-specific memory CD8+ T lymphocytes |
| Q84588320 | Prolonged lymphocyte depletion by single-dose rabbit anti-thymocyte globulin and alemtuzumab in kidney transplantation |
| Q36842568 | Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells |
| Q45148312 | Recent thymic origin, differentiation, and turnover of regulatory T cells |
| Q37474900 | Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells |
| Q41849574 | Regulation gone wrong: a subset of Sézary patients have malignant regulatory T cells |
| Q42554303 | Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors. |
| Q37903852 | Regulatory T cells in gastrointestinal tumors |
| Q37129619 | Regulatory T cells in systemic lupus erythematosus: past, present and future |
| Q51765736 | Regulatory T cells in type 1 diabetic patients with autoimmune chronic atrophic gastritis. |
| Q42786356 | Regulatory T cells: stability revisited |
| Q35384216 | Regulatory T-cell Trafficking: From Thymic Development to Tumor-Induced Immune Suppression |
| Q34464401 | Regulatory T-cells and associated pathways in metastatic renal cell carcinoma (mRCC) patients undergoing DC-vaccination and cytokine-therapy |
| Q37914338 | Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis |
| Q40013872 | STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells. |
| Q33873997 | Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients |
| Q38088063 | Subpopulations of helper T lymphocytes in tuberculous pleurisy |
| Q33977826 | Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses |
| Q37967572 | Suppression assays with human T regulatory cells: a technical guide. |
| Q53162837 | Suppressor Properties of Human CD8(+)CD28(-) T Cells in Mixed Leukocyte Reaction are not Affected by CsA and RAPA. |
| Q33488520 | Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors |
| Q36967375 | T cell receptor (TCR) and transforming growth factor β (TGF-β) signaling converge on DNA (cytosine-5)-methyltransferase to control forkhead box protein 3 (foxp3) locus methylation and inducible regulatory T cell differentiation |
| Q37018222 | T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. |
| Q45365327 | T-regulatory cells infected with feline immunodeficiency virus up-regulate programmed death-1 (PD-1). |
| Q37528532 | TGF-β Affects the Differentiation of Human GM-CSF+ CD4+ T Cells in an Activation- and Sodium-Dependent Manner |
| Q37250644 | The Nature of Increased Circulating CD4CD25Foxp3 T Cells in Patients with Systemic Lupus Erythematosus: A Novel Hypothesis |
| Q38856516 | The Role of IFN-alpha in Experimental and Clinical Uveitis |
| Q84923161 | The dynamic changes of T-bet(+)/GATA-3(+) and RORgammat(+)/FOXP3(+) cells in recipient spleens and grafts after rat orthotopic liver transplantation |
| Q46046855 | The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4⁺CD25⁺ regulatory T cells |
| Q44041381 | The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent. |
| Q42954783 | The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation. |
| Q84443643 | The imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients |
| Q43233982 | The importance of the nurse cells and regulatory cells in the control of T lymphocyte responses |
| Q38129079 | The role of FOXP3 in regulating immune responses |
| Q37272092 | The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease |
| Q30371308 | The role of regulatory T cells in atopic dermatitis. |
| Q27004368 | The role of regulatory T cells in the pathogenesis of sepsis and its clinical implication |
| Q34103905 | The role of the thymus in tolerance |
| Q30423165 | The vaccine-site microenvironment induced by injection of incomplete Freund's adjuvant, with or without melanoma peptides |
| Q55287352 | Time-resolved transcriptome and proteome landscape of human regulatory T cell (Treg) differentiation reveals novel regulators of FOXP3. |
| Q27008946 | Treg functional stability and its responsiveness to the microenvironment |
| Q34001211 | Tumor antigen epitopes interpreted by the immune system as self or abnormal-self differentially affect cancer vaccine responses |
| Q97537455 | Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer |
| Q33882469 | Type-I IFN signaling suppresses an excessive IFN-gamma response and thus prevents lung damage and chronic inflammation during Pneumocystis (PC) clearance in CD4 T cell-competent mice |
| Q26863525 | Ubiquitin-dependent regulation of Foxp3 and Treg function |
| Q52677986 | Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease. |
| Q46952293 | Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia |
| Q28249415 | Use of epigenetic modification to induce FOXP3 expression in naïve T cells |
Search more.